Assessing the impact of comorbidities on disease severity in COVID-19 patients requires consideration of age

评估合并症对新冠肺炎患者疾病严重程度的影响需要考虑年龄因素。

阅读:1

Abstract

Older age and comorbidities are risk factors for increased coronavirus disease 2019 (COVID-19) severity, but few studies have explored their interaction. This study aimed to assess the actual impacts of these factors on disease severity in COVID-19. The enrolled COVID-19 patients were divided into 4 age subgroups (≤44, 45-59, 60-74, and ≥75 years). Logistic regression analysis was conducted to determine the association between comorbidities and disease severity; Kappa consistency test was implemented to verify the study results. Of the 1663 patients with COVID-19, 287 had severe disease. The disease severity was correlated with the age-adjusted Charlson Comorbidity Index in each age group. In the 4 subgroups, the odds ratio of age-adjusted Charlson Comorbidity Index declined with age. After removing age interference, diabetes and cardio-cerebrovascular diseases were the main risk factors for severe disease in patients aged <75 years, whereas only chronic lung disease was associated with disease severity in patients aged ≥75 years. When comorbidities alone were used to predict disease severity, only the predictions were consistent with real outcomes in patients aged ≥75 years, compared with the predictions of high-risk comorbidities mentioned in World Health Organization and Chinese guidelines (Kappa 0.106, P < .05). Although older age and comorbidities were risk factors for severe COVID-19, their effects on disease severity varied across age groups. Additionally, comorbidities had a greater impact on COVID-19 severity in younger patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。